Proceedings of the Engineering and Physical Sciences Research Council Workshop—the development of functional imaging in the diagnosis, management and understanding of childhood brain tumours
暂无分享,去创建一个
S. Williams | C. R. Pinkerton | M. Leach | R. Grundy | A. Peet | S R Williams | A C Peet | M O Leach | C R Pinkerton | P Price | R G Grundy | M. O. Leach | A. Peet | P. Price | S. Williams | C. Pinkerton | Patricia Price
[1] W. J. Oakes,et al. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. , 1993, Medical and pediatric oncology.
[2] Franklyn A. Howe,et al. Comparison of in vivo1H MRS of human brain tumours with1H HR-MAS spectroscopy of intact biopsy samples in vitro , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.
[3] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[4] A. Thiel,et al. 11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.
[5] F. Shishido,et al. Positron Emission Tomographic Evaluations in the Diagnosis and Therapy of Multifocal Glioblastoma , 1985 .
[6] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[7] K. Lamborn,et al. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. , 1999, Journal of pediatric hematology/oncology.
[8] E. Zackai,et al. Intracranial visual pathway gliomas in children with neurofibromatosis. , 1988, Neurofibromatosis.
[9] J. Smirniotopoulos,et al. Pineal Parenchymal Tumors: CT and MR Features , 1995, Journal of computer assisted tomography.
[10] E C Halperin,et al. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. , 1989, International journal of radiation oncology, biology, physics.
[11] Audrey E. Evans,et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial , 1989, Journal of Neuro-Oncology.
[12] M. Leach,et al. Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques , 2001, British Journal of Cancer.
[13] Positron emission tomography-guided stereotactic brain biopsy. , 1992 .
[14] M. Leach,et al. Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells , 2001, British Journal of Cancer.
[15] M. Leach,et al. Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer. , 2003, European journal of cancer.
[16] T. Hölzer,et al. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine. , 1997, Neurosurgery.
[17] C. Gondry-Jouet,et al. Differential MRI diagnosis between brain abscesses and necrotic or cystic brain tumors using the apparent diffusion coefficient and normalized diffusion-weighted images. , 2003, Magnetic resonance imaging.
[18] S. Williams,et al. Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. , 1995, Cancer research.
[19] K Wienhard,et al. Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] F. Berthold,et al. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment , 1993, Cancer.
[21] K. Bergström,et al. MULTIPLANAR SPINAL ANATOMY: COMPARISON OF COMPUTED TOMOGRAPHY AND CRYOMICROTOMY IN POSTMORTEM SPECIMENS , 1983 .
[22] C. Presant,et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response , 1994, The Lancet.
[23] K. Brindle. Metabolomics: Pandora's Box or Aladdin's Cave? , 2003 .
[24] P. Courtheoux,et al. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. , 1997, Neurosurgery.
[25] L. J. Rubinstein,et al. Tumours of the central nervous system , 1979, Oxford Desk Reference: Oncology.
[26] Pek-Lan Khong,et al. Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study. , 2003, AJNR. American journal of neuroradiology.
[27] A R Tate,et al. Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.
[28] D. Thomas,et al. Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks. , 1997, Cancer research.
[29] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[30] A. Paller. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study , 1995 .
[31] G. Perilongo,et al. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. , 1998, Medical and pediatric oncology.
[32] A. Luxen,et al. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy , 1995, Acta Neurochirurgica.
[33] J Hildebrand,et al. Positron emission tomography-guided stereotactic brain biopsy. , 1992, Neurosurgery.
[34] P. Robinson,et al. MEASUREMENT OF BLOOD‐BRAIN BARRIER PERMEABILITY , 1990, Clinical and experimental pharmacology & physiology.
[35] L. Rorke,et al. Prognostic factors in childhood ependymomas. , 1990, Pediatric neurosurgery.
[36] P. Basser,et al. In vivo fiber tractography using DT‐MRI data , 2000, Magnetic resonance in medicine.
[37] D. R. Wilkie,et al. 31P-NMR STUDIES OF A HUMAN TUMOUR IN SITU , 1983, The Lancet.
[38] S. Osman,et al. Metabolic activation of temozolomide measured in vivo using positron emission tomography. , 2003, Cancer research.
[39] D. Ellison,et al. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. , 2002, The American journal of pathology.
[40] A. Luxen,et al. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. , 1995, Journal of neurosurgery.
[41] J L Ackerman,et al. Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic‐angle spinning , 1996, Magnetic resonance in medicine.
[42] M. Muti,et al. Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas. , 2002, Magnetic resonance imaging.
[43] R. Gupta,et al. Variation of post-treatment H-MRSI choline intensity in pediatric gliomas. , 1999, Journal of neuro-oncology.
[44] C. Degueldre,et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] M. Leach,et al. Initial measurements of ifosfamide and cyclophosphamide in patients using 31P MRS: Pulse‐and‐acquire, decoupling, and polarization transfer , 2000, Magnetic resonance in medicine.
[46] Sinisa Pajevic,et al. Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: Application to white matter fiber tract mapping in the human brain , 1999, Magnetic resonance in medicine.
[47] A. Kirton,et al. Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[48] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[49] D. Collins,et al. Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without interferon-alpha. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[50] G. Reifenberger,et al. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas , 2002, Child’s Nervous System.
[51] W. J. Oakes,et al. FDG-PET in pediatric posterior fossa brain tumors. , 1992, Journal of computer assisted tomography.
[52] Reiman,et al. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. , 2000, Journal of neurosurgery.
[53] C. Meyer,et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. , 2002, Molecular imaging.
[54] J D Pickard,et al. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion? , 2003, Clinical radiology.
[55] Emanuel Petricoin,et al. Molecular profiling of human cancer , 2000, Nature Reviews Genetics.
[57] Mark Noble,et al. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours , 1995, NMR in biomedicine.
[58] Susan M. Chang,et al. Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. , 2001, Magnetic resonance imaging.
[59] R B Banati,et al. PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.
[60] K. Någren,et al. Metabolic characterization of childhood brain tumors , 2002, Cancer.
[61] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[62] A Brun,et al. Tumours of the Central Nervous System , 1986, Acta radiologica: diagnosis.
[63] Ting-Yim Lee,et al. An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[64] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[65] J. Charrow,et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.
[66] Douglas B. Kell,et al. Metabolomics and Machine Learning: Explanatory Analysis of Complex Metabolome Data Using Genetic Programming to Produce Simple, Robust Rules , 2004, Molecular Biology Reports.
[67] S. Goldman,et al. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[68] P. Kleihues,et al. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. , 1988, Journal of neurosurgery.
[69] V. Sturm,et al. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds. , 1997, Stereotactic and functional neurosurgery.
[70] J. Alger,et al. Variation of Post-treatment H-MRSI Choline Signal Intensity in Pediatric Gliomas , 1999, Journal of Neuro-Oncology.
[71] Paul Van Houtte,et al. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the Leksell gamma knife: early experience with brain tumors , 2009 .
[72] R. Zimmerman,et al. Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children , 1998, Neuroradiology.
[73] W. Negendank,et al. Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.
[74] T Metens,et al. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note. , 2000, Journal of neurosurgery.
[75] O. Schober,et al. Monitoring tumor activity in low grade glioma of childhood , 1998, Klinische Padiatrie.
[76] S. Williams,et al. Immortalization and transformation are associated with specific alterations in choline metabolism. , 1996, Cancer research.
[77] Bradford A. Moffat,et al. Diffusion MRI: A New Strategy for Assessment of Cancer Therapeutic Efficacy , 2002, Molecular imaging.
[78] S. Goldman,et al. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine. , 1997, Acta neurochirurgica. Supplement.
[79] J. R. Griffiths. Clinical applications of MR spectroscopy , 1999 .
[80] D. Arnold,et al. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors , 1998, NMR in biomedicine.
[81] Leo L. Cheng,et al. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. , 2000, Neuro-oncology.
[82] T Greitz,et al. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. , 1983, Journal of computer assisted tomography.
[83] R. K. Jain,et al. Vessels of death or life. , 2001, Scientific American.
[84] D. Louis Collins,et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.
[85] C. Spenger,et al. Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS) , 2003, British Journal of Cancer.
[86] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[87] L. Drubach,et al. Applications of Nuclear Medicine in Pediatric Oncology , 2002, Clinical nuclear medicine.
[88] S. Osman,et al. Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies. , 2002, Cancer research.
[89] F Ståhlberg,et al. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. , 2000, AJNR. American journal of neuroradiology.
[90] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .
[91] S. Bertolone,et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[92] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.